Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices

NCT01255943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2021-11-09

No results posted yet for this study

Summary

The purpose of this study is to implement strategies for improved efficiency and waste reduction ("Toyota Lean") and positive deviance, a social behavioral change process, utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA infection in outpatient dialysis care. In two outpatient dialysis units, dialysis unit healthcare staff will be educated in Toyota lean techniques and conduct periodic "discovery and action" dialogues to identify and implement care process changes to reduce infection. Outcomes to be monitored will include incidence of bloodstream infections and MRSA infections of all types. Data will be assessed at quarterly intervals using interrupted time series analysis.

Conditions

  • Blood Stream Infections
  • MRSA Infections

Interventions

BEHAVIORAL

healthcare staff processes for infection prevention

Toyota lean and positive deviance discovery and action dialogues to facilitate process improvement

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED
  • Indiana University School of Medicine

    collaborator OTHER
  • MaineHealth

    lead OTHER

Principal Investigators

  • Mark G Parker, MD · MaineHealth

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01255943 on ClinicalTrials.gov